Standardized healthcare-center-centered care of DSD over the life spa

• Conditions: K43.6; Q56; Q55.8; Q64.1; Q51.8; E25.0; E28.3; E29.1; E29.9; E34.5

• Registration Number: DRKS00022521
• Lead Sponsor: niversitätsklinikum Schleswig-HolsteinKlinik für Kinder- und JugendmedizinSektion Pädiatrische Endokrinologie und Diabetologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-04-14
• Study Completion: 2023-06-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 596

Inclusion Criteria

Diagnosis of DSD according to Chicago Classification 2005 OR
- overt genital ambiguity
- apparent female genitalia with an enlarged clitoris, posterior labial fusion, or an inguinal/labial mass
- apparent male genitalia with bilateral undescended testes, micropenis, isolated perineal hypospadias, or mild hypospadias with undescended testes
- discordance between genital appearance and a prenatal karyotype
- female phenotype with pubertal virilization and/or primary amenorrhea and/or no thelarche
- male phenotype with pubertal hypovirilization
AND written consent to participate in the study

Exclusion Criteria

- acquired hypogonadotropic hypogonadism
- no written consent

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Structural and process quality of care

Secondary Outcome Measures

Name	Time	Method
Outcome quality